Linxue Huang, Tao Mai, Xiyuan Zhou, Ling Zhong, Jia Su, Mingyi Chen et al. Silencing SLC52A2 promotes tertiary lymphoid structure formation and inhibits IL-17 pathway to ameliorate melanoma progression. // Apoptosis. – 2026. – DOI: 10.1007/s10495-026-02433-9. – URL: https://doi.org/10.1007/s10495-026-02433-9
Linxue Huang, Tao Mai, Xiyuan Zhou, Ling Zhong, Jia Su, Mingyi Chen, & Huiying Wan (2026). Silencing SLC52A2 promotes tertiary lymphoid structure formation and inhibits IL-17 pathway to ameliorate melanoma progression. Apoptosis. https://doi.org/10.1007/s10495-026-02433-9
Linxue Huang, et al. “Silencing SLC52A2 promotes tertiary lymphoid structure formation and inhibits IL-17 pathway to ameliorate melanoma progression.” Apoptosis, 2026. doi:10.1007/s10495-026-02433-9.
@article{Huang2026,
title = {Silencing SLC52A2 promotes tertiary lymphoid structure formation and inhibits IL-17 pathway to ameliorate melanoma progression},
author = {Huang, Linxue and Mai, Tao and Zhou, Xiyuan and Zhong, Ling and Su, Jia and Chen, Mingyi and Wan, Huiying},
journal = {Apoptosis},
year = {2026},
doi = {10.1007/s10495-026-02433-9},
url = {https://doi.org/10.1007/s10495-026-02433-9}
}